Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Abb Vie Inc. Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 33,152 shares of ABBV stock, worth $6.31 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
33,152
Previous 39,026
15.05%
Holding current value
$6.31 Million
Previous $8.18 Million
24.74%
% of portfolio
0.14%
Previous 0.21%
Shares
31 transactions
Others Institutions Holding ABBV
# of Institutions
4,252Shares Held
1.27BCall Options Held
16.8MPut Options Held
15.3M-
Vanguard Group Inc Valley Forge, PA174MShares$33.1 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.2 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.83 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $336B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...